Mirion Technologies, Inc. ("Mirion") (NYSE: MIR), today announced the pricing of an underwritten public offering of 17,309,846 shares of Mirion's Class A common stock at a public offering price of $21.35 per share (the "common stock offering"). The size of the common stock offering was increased from the previously announced $350.0 million of shares of Class A common stock. In addition, Mirion granted the underwriters an option to purchase up to an additional 2,596,476 shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The common stock offering is expected to close on September 30, 2025, subject to the satisfaction of customary closin

Mirion Technologies, Inc. ("Mirion") (NYSE:MIR), today announced the pricing of $325.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "notes") in a private placement (the "convertible notes offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The size of the convertible notes offering was increased from the previously announced $250.0 million aggregate principal amount of notes. In addition, Mirion granted the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the n

Mirion Technologies, Inc. ("Mirion") (NYSE:MIR), today announced its intent to offer $250.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the "notes") in a private placement (the "convertible notes offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Mirion also intends to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $37.5 million aggregate principal amount of notes. The convertible notes offering is subject to ma

Mirion Technologies, Inc. ("Mirion") (NYSE:MIR) today announced the commencement of an underwritten public offering of $350.0 million of shares of Mirion's Class A common stock (the "common stock offering"). Mirion also intends to grant the underwriters a 30-day option to purchase up to an additional $50.0 million of shares of its Class A common stock at the public offering price, less underwriting discounts and commissions. The common stock offering is subject to market and other conditions, and there can be no assurance as to whether or when the common stock offering may be completed or as to the actual size or terms of the common stock offering. Goldman Sachs & Co. LLC, Evercore ISI, C

Broadens Mirion's portfolio of offerings for nuclear power customers, including SMRs Attractive purchase price of $585 million in cash Accretive to diluted EPS within the first full year post acquisition Creates path to anticipated commercial and cost synergies of $10 million Brings best-in-class talent to Mirion with long-term relationships with nuclear OEMs Mirion to host conference call and live webcast on September 24 at 10:00 a.m. ET Mirion ("we" or the "company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, has entered into a definitive agreement to a

Partnership Agreement to Strengthen Radiation Detection and Measurement Capabilities at the Terrestrial Environmental Radiochemistry (TERC) Laboratory, Safeguarding the Environment and Promoting Nuclear Safety Mirion (NYSE:MIR), a leading provider of advanced radiation safety solutions, has signed a partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA), the world's central intergovernmental forum for scientific and technical cooperation in the nuclear field, to cooperate in the area of radiation detection and measurement. Through this collaboration, Mirion's advanced instrumentation and profound understanding of ionizing radiation will combine

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Mirion Technologies Inc. (NYSE:MIR) will replace GMS Inc. (NYSE:GMS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 9. S&P 500 and 100 constituent Home Depot Inc. (NYSE:HD) acquired GMS in a deal that was completed today. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector September 9, 2025 S&P SmallCap 600 Addition Mirion Technologies MIR Information Technology September 9, 2025 S&P SmallCap 600 Deletion GMS GMS Industrials For more information about S&P Dow Jones Indices, please visit www

Revenue for the second quarter increased 7.6% to $222.9 million, compared to $207.1 million in the same period in 2024. GAAP net income was $8.5 million in the second quarter, compared to a GAAP net loss of $12.0 million in the same period in 2024; a 171% improvement. Adjusted EBITDA was $51.2 million in the second quarter, a 4.9% increase from $48.8 million in the same period in 2024. GAAP net earnings per share in the second quarter was $0.04, compared to a GAAP net loss per share of $0.06 in the same period in 2024. Adjusted earnings per share for the quarter was $0.11, compared to $0.10 in the same period in 2024. The company raised guidance for total Revenue growth, Adjusted

The acquisition strengthens Mirion's position across nuclear power facilities and supports commitment to safely meeting rising global energy demand. Mirion (NYSE:MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced the acquisition of Certrec, a leading supplier of regulatory compliance and digital integration solutions for the energy industry. Operating out of Fort Worth, TX, Certrec solutions help ensure a stable and reliable bulk electric supply. Since 1988, Certrec's innovation and industry expertise has helped hundreds of power-generating facilities reduce risk an

Mirion (NYSE:MIR) announced today that it will release financial results for second quarter 2025 after market close on Thursday, July 31, 2025. Following the news release, the company will host a conference call the next day, Friday, August 1, 2025, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with ac

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Mirion Technologies Inc. (NYSE:MIR) will replace GMS Inc. (NYSE:GMS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 9. S&P 500 and 100 constituent Home Depot Inc. (NYSE:HD) acquired GMS in a deal that was completed today. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector September 9, 2025 S&P SmallCap 600 Addition Mirion Technologies MIR Information Technology September 9, 2025 S&P SmallCap 600 Deletion GMS GMS Industrials For more information about S&P Dow Jones Indices, please visit www

SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control

Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le

Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Dr. Sheila Rege, M.D. has been appointed to the Board of Directors, replacing Mr. Christopher Warren, who is stepping down. Lawrence D. Kingsley, Chairman of Mirion's Board of Directors said, "I am pleased to welcome Sheila to Mirion's Board of Directors. She brings deep experience and a long track record of accomplishment in nuclear medicine and radiation oncology to Mirion's Board. We are excited to have Sheila join us and believe that her diverse sk

SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13G - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13G - Mirion Technologies, Inc. (0001809987) (Subject)

SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

Broadens Mirion's portfolio of offerings for nuclear power customers, including SMRs Attractive purchase price of $585 million in cash Accretive to diluted EPS within the first full year post acquisition Creates path to anticipated commercial and cost synergies of $10 million Brings best-in-class talent to Mirion with long-term relationships with nuclear OEMs Mirion to host conference call and live webcast on September 24 at 10:00 a.m. ET Mirion ("we" or the "company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, has entered into a definitive agreement to a

Revenue for the second quarter increased 7.6% to $222.9 million, compared to $207.1 million in the same period in 2024. GAAP net income was $8.5 million in the second quarter, compared to a GAAP net loss of $12.0 million in the same period in 2024; a 171% improvement. Adjusted EBITDA was $51.2 million in the second quarter, a 4.9% increase from $48.8 million in the same period in 2024. GAAP net earnings per share in the second quarter was $0.04, compared to a GAAP net loss per share of $0.06 in the same period in 2024. Adjusted earnings per share for the quarter was $0.11, compared to $0.10 in the same period in 2024. The company raised guidance for total Revenue growth, Adjusted

The acquisition strengthens Mirion's position across nuclear power facilities and supports commitment to safely meeting rising global energy demand. Mirion (NYSE:MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced the acquisition of Certrec, a leading supplier of regulatory compliance and digital integration solutions for the energy industry. Operating out of Fort Worth, TX, Certrec solutions help ensure a stable and reliable bulk electric supply. Since 1988, Certrec's innovation and industry expertise has helped hundreds of power-generating facilities reduce risk an

Mirion (NYSE:MIR) announced today that it will release financial results for second quarter 2025 after market close on Thursday, July 31, 2025. Following the news release, the company will host a conference call the next day, Friday, August 1, 2025, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with ac

Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

 Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece

Mirion (NYSE:MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until February 26, 2025. Participants may access the replay at 1-844-512-2921

Revenues for the third quarter increased 8.2% to $206.8 million, compared to $191.2 million in the same period in 2023. Net loss was $14.0 million in the third quarter, compared to a net loss of $12.9 million in the same period last year. Adjusted EBITDA was $45.7 million, a 17.8% increase from $38.8 million in the same period last year. Loss from operations margin was 0.8% in the third quarter, compared to 5.8% in the same period in 2023. Adjusted EBITDA margin was 22.1% in the third quarter, compared to 20.3% in the same period last year. GAAP net loss per share for the third quarter was $0.07, compared to $0.06 in the third quarter of 2023. Adjusted earnings per share for the q

Mirion (NYSE:MIR) announced today that it will release financial results for third quarter 2024 after market close on Tuesday, October 29, 2024. Following the news release, the company will host a conference call the next day, Wednesday, October 30, 2024, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until November 13, 2024. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 w